Professor Baigent researches cardiovascular epidemiology. He works on the design, conduct and application of large-scale randomised trials in cardiovascular disease. His research has helped determine the effects of aspirin, non-steroidal anti-inflammatory drugs (such as ibuprofen and naproxen), fibrinolytic therapy, and statins in different types of patients. His group has also contributed to a better understanding of cardiovascular disease in patients with renal impairment through the Study of Heart and Renal Protection (SHARP), the largest ever in patients with moderate-to-severe chronic kidney disease.
- Kidney disease
- Non-steroidal anti-inflammatory drugs
Professor Baigent has extensive media experience in radio and TV, both live and pre-recorded, and in print and online media.